{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:20:36Z","timestamp":1768713636512,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Bio and Agro-Defense Facility Transition Fund","award":["KBA-CBRI 611310"],"award-info":[{"award-number":["KBA-CBRI 611310"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 AI085416"],"award-info":[{"award-number":["R21 AI085416"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007765","name":"Kansas State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.04.065","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T11:59:00Z","timestamp":1430567940000},"page":"2903-2908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines"],"prefix":"10.1016","volume":"33","author":[{"given":"A.","family":"Galliher-Beckley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.K.","family":"Pappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Madera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Burakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nickles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nietfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Schlup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"McVey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Dritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.vaccine.2015.04.065_bib0120","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1016\/j.vaccine.2007.04.089","article-title":"Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine: and an effective stimulus of in vivo immune response","volume":"25","author":"Cheng","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.065_bib0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-2427(99)00035-5","article-title":"Improvement of the immune response to foot and mouth disease virus vaccine in calves by using Avridine as adjuvant","volume":"69","author":"Sadir","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2015.04.065_bib0130","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","article-title":"Unmet needs in modern vaccinology: adjuvants to improve the immune response","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.04.065_bib0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.065_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08923973.2014.971963","article-title":"Cancer vaccine adjuvants\u2014recent clinical progress and future perspectives","volume":"37","author":"Banday","year":"2015","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.065_bib0145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.icb.7100151","article-title":"Vaccination against self to prevent autoimmune disease: the type 1 diabetes model","volume":"86","author":"Harrison","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.04.065_bib0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40521-014-0013-1","article-title":"Allergen-specific immunotherapy in asthma","volume":"1","author":"Jutel","year":"2014","journal-title":"Curr Treat Options Allergy"},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.065_bib0155","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1172\/JCI72061","article-title":"Emerging therapies for food allergy","volume":"124","author":"Keet","year":"2014","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.065_bib0160","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.4049\/jimmunol.155.5.2715","article-title":"A zona pellucida 3 peptide vaccine induces antibodies and reversible infertility without ovarian pathology","volume":"155","author":"Lou","year":"1995","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.04.065_bib0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0897.1996.tb00028.x","article-title":"ZP3 peptide vaccine that induces antibody and reversible infertility without autoimmune oophoritis","volume":"35","author":"Tung","year":"1996","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.065_bib0170","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2008.04.036","article-title":"Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens","volume":"364","author":"Perrie","year":"2008","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.065_bib0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/erv.10.142","article-title":"Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens","volume":"10","author":"Dey","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"15","key":"10.1016\/j.vaccine.2015.04.065_bib0180","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2174\/0929867033457340","article-title":"Synthetic vaccines: the role of adjuvants in immune targeting","volume":"10","author":"Jiang","year":"2003","journal-title":"Curr Med Chem"},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.065_bib0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.04.065_bib0190","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2012.03.008","article-title":"Adjuvants for human vaccines","volume":"24","author":"Alving","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.065_bib0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rvsc.2005.10.007","article-title":"Emulsifier content and side effects of oil-based adjuvant vaccine in swine","volume":"81","author":"Oda","year":"2006","journal-title":"Res Vet Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.065_bib0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/104063870902100113","article-title":"Performance of a commercial Swine influenza virus H1N1 and H3N2 antibody enzyme-linked immunosorbent assay in pigs experimentally infected with European influenza viruses","volume":"21","author":"Barbe","year":"2009","journal-title":"J Vet Diagn Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.065_bib0205","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2015.04.065_bib0210","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2015.04.065_bib0215","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/jps.24337","article-title":"The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of droplet size on performance","volume":"104","author":"Shah","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2015.04.065_bib0220","article-title":"Efficacy of FluSure XP\u2122in pigs challenged with either a heterologous reassortant H3N2 or H1N1 swine influenza virus","author":"Kuhn","year":"2009","journal-title":"Pfizer Anim Health Tech Bull"},{"issue":"17","key":"10.1016\/j.vaccine.2015.04.065_bib0225","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1128\/JVI.01038-13","article-title":"Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011\u20132012 H3N2v","volume":"87","author":"Loving","year":"2013","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.04.065_bib0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1556\/AVet.51.2003.3.2","article-title":"Reduction of economic losses caused by mycoplasmal pneumonia of pigs by vaccination with Respisure and by Tiamutin treatment","volume":"51","author":"Stipkovits","year":"2003","journal-title":"Acta Vet Hung"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15005411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15005411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:54:04Z","timestamp":1691628844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15005411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":23,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15005411"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}